Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer
A phase 3 trial of Dexamethasone, Palonosetron and Netupitant and palonosetron in Breast cancer, run by University of Rochester NCORP Research Base, completed.
Overview
Treatment of Refractory Nausea and Vomiting in Patients With Breast Cancer is a phase 3 interventional study registered as NCT03367572 by University of Rochester NCORP Research Base, with 1363 participants recorded, started 2018-04-19 and reaching its primary completion in 2024-04-13. Interventions recorded: Dexamethasone, Laboratory Biomarker Analysis, Netupitant/Palonosetron Hydrochloride, Olanzapine, Placebo, Prochlorperazine, Quality-of-Life Assessment. Conditions recorded: Breast Carcinoma.
Linked to the drug Netupitant and palonosetron because the registry names it among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialAKY15-HK-301_NEPA Study
Shares Netupitant and palonosetron, Breast cancer (all types) and the tag pipeline.
- TrialSafety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
Shares Netupitant and palonosetron, Dexamethasone and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialStudy With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
Shares Palonosetron and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.